THE CLINICAL CASES OF KERATOCONJUNCTIVITIS ENCOUNTERED IN THE PEDIATRIC PATIENTS PRESENTING WITH ATOPIC DERMATITIS

I. E Panova; Lyudmila Anatol’evna Patlasova; L. A Chervonyak; E. P Tagieva

doi:10.18821/1993-1859-2017-12-2-113-116

Russian Pediatric Ophthalmology ›› 2017, Vol. 12 ›› Issue (2) : 113 -116. DOI: 10.18821/1993-1859-2017-12-2-113-116

Articles

research-article

THE CLINICAL CASES OF KERATOCONJUNCTIVITIS ENCOUNTERED IN THE PEDIATRIC PATIENTS PRESENTING WITH ATOPIC DERMATITIS

Author information +

History +

PDF

Abstract

The eye damage in the children presenting with atopic dermatitis is known to occur in 20-40% of the cases. The nonspecific nature of the ophthalmological symptoms of this pathology markedly complicates differential diagnostics and the choice of the pathogenetically-based therapeutic modalities. This article describes the clinical cases that demonstrate the seriousness of this problem and illustrate the necessity of the comprehensive interdisciplinary approach to its solution. It is concluded that the use of the “Restasis” pharmaceutical for the treatment of dry eye syndrome associated with atopic dermatitis in the young patients is justified as contributing to a stable remission of the disorder and producing no undesirable side effects.

Keywords

keratoconjunctivitis / atopic dermatitis / clinical case / : children

Cite this article

Download citation ▾

I. E Panova, Lyudmila Anatol’evna Patlasova, L. A Chervonyak, E. P Tagieva. THE CLINICAL CASES OF KERATOCONJUNCTIVITIS ENCOUNTERED IN THE PEDIATRIC PATIENTS PRESENTING WITH ATOPIC DERMATITIS. Russian Pediatric Ophthalmology, 2017, 12(2): 113-116 DOI:10.18821/1993-1859-2017-12-2-113-116

登录浏览全文

4963

注册一个新账户忘记密码

References

Publishing order | Descend order by publishing year | Descend order by cited within

[1]	Федеральные клинические рекомендации по оказанию медицинской помощи детям с атопическим дерматитом / Под ред. акад. РАН А.А. Баранова, чл.-корр. РАН Л.С. Намазовой-Барановой [Электронный ресурс] // URL: http://www.pediatr-russia.ru/sites/default/files/file/kr_ad.pdf (дата обращения 27.07.2016).

[2]	Watson W., Kapur S. Atopic dermatitis. Allergy, Asthma Clin. Immunol. 2011; 7 (Suppl. 1): S4. [Электронный ресурс] // URL: http://aacijournal.biomedcentral.com/articles/10.1186/1710-1492-7-S1-S4. (дата обращения 27.07.2016).

[3]	Самцов А.В., Соколовский Е.В., Аравийская Е.А. Рекомендации по лечению топического дерматита (атопической экземы) Американской академии дерматологии, Европейской академии дерматовенерологии и Российского общества дерматовенерологов и косметологов. Вестн. дерматол. 2015; (6): 11-6.

[4]	Майчук Ю.Ф. Конъюнктивиты. Современная лекарственная терапия: Краткое пособие для врачей. 2-е изд. М.; 2014.

[5]	Van der Merwe R., Gianella-Borradori А. Industry Perspective on the Clinical Development of Systemic Products for the Treatment of Atopic Dermatitis in Pediatric Patients with Inadequate Response to Topical Prescription Therapy. Dermatologic and Ophthalmic Drugs Advisory Committee Meeting; 2015.

[6]	Akpek E K., Dart J. K., Watson St., Christen W., Dursun D., Yoo S., et al. A randomised trial of topical cyclosporin 0.05% in topical steroid-resistant atopic keratoconjunctivitis. Ophthalmology. 2004; 111 (3); 476.